Abstract:Subsequently to the publication of the above article, and a Corrigendum that has already been published with the intention of showing corrected versions of Figs. 1 and 8 (DOI: 10.3892/or.2022.8348; published online on June 14, 2022), the authors have belatedly realized that the revisions made to Fig. 8 necessitated changes that should have been introduced into Fig. 9, although these were not attended to in the first corrigendum. Essentially, Fig. 8 was revised as the cell apoptosis and cell proliferation assays therein were poorly presented, which made the interpretation of the data difficult; Fig. 9 showed the fractions of apoptotic cells in the SKM‑1 and THP‑1 cell lines with lncENST00000444102 overexpression as this pertained to Fig. 8. A revised version of Fig. 9, presenting the analysis of the data shown in the revised version of Fig. 8, is shown opposite. In addition to the revision of Fig. 9, the sentence starting on p. 517, left‑hand column, line 12 [“The flow cytometric apoptosis assay revealed that lncENST00000444102 overexpression promoted tumor cells to undergo apoptosis compared to control cells (P<0.001, Fig. 9)”] should be replaced with the following text, to reflect the change in the level of statistical significance: ‘The flow cytometric apoptosis assay revealed that lncENST00000444102 overexpression promoted tumor cells to undergo apoptosis compared to control cells (P<0.01, Fig. 9)”. Note that the revisions made to Figs. 8 and 9 in this paper have not had a major impact on the reported results, and do not affect the overall conclusions reported in the study. All the authors agree to the publication of this corrigendum. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this additional Corrigendum; furthermore, they apologize for any inconvenience caused to the readership of the Journal. [Oncology Reports 42: 509‑520, 2019; DOI: 10.3892/or.2019.7175]

Author Correction: BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells

Publisher Correction: the Transcriptional Coactivator TAZ Regulates Reciprocal Differentiation of TH17 Cells and Treg Cells.

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Erratum: Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers

Erratum: Deconstructing transcriptional heterogeneity in pluripotent stem cells

Author Correction: Suppression of M 6 A Reader Ythdf2 Promotes Hematopoietic Stem Cell Expansion

Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity

Publisher Correction: The transcriptional cofactor Tle3 reciprocally controls effector and central memory CD8 + T cell fates

Author Correction: Topoisomerase IIα controls the decatenation checkpoint

Author Correction: Anti-tumour Immunity Controlled Through Mrna M 6 A Methylation and YTHDF1 in Dendritic Cells

Publisher Correction: Chromatin Dysregulation and DNA Methylation at Transcription Start Sites Associated with Transcriptional Repression in Cancers

Author Correction: Linc-DYNC2H1-4 Promotes EMT and CSC Phenotypes by Acting As a Sponge of Mir-145 in Pancreatic Cancer Cells

Author Correction: Transcription factor competition at the γ-globin promoters controls hemoglobin switching

Correction To: Identification of TAZ As the Essential Molecular Switch in Orchestrating SCLC Phenotypic Transition and Metastasis.

Publisher Correction: Immune Genes Are Primed for Robust Transcription by Proximal Long Noncoding RNAs Located in Nuclear Compartments

Correction To: Transcriptional Activation of CBFβ by CDK11p110 is Necessary to Promote Osteosarcoma Cell Proliferation

The role of Bach2 in regulating CD8 + T cell development and function

Author Correction: NOTCH localizes to mitochondria through the TBC1D15-FIS1 interaction and is stabilized via blockade of E3 ligase and CDK8 recruitment to reprogram tumor-initiating cells

[Corrigendum] Role of 4‑aminobutyrate Aminotransferase (ABAT) and the Lncrna Co‑expression Network in the Development of Myelodysplastic Syndrome

Author Correction: PAK1 confers chemoresistance and poor outcome in non-small cell lung cancer via β-catenin-mediated stemness

Author Correction: the Evolving Metabolic Landscape of Chromatin Biology and Epigenetics